How Innovative Therapies Propel the Anti-VEGF Market Growth
The Anti-VEGF market is on a trajectory of robust growth, driven by groundbreaking treatments and an increasing incidence of ocular diseases. By 2024, the market is anticipated to reach $25.98 billion, followed by an increase to $27.10 billion in 2025, ultimately hitting $41.3 billion by 2035. This growth narrative is underpinned by a compound annual growth rate (CAGR) of 4.30% during the...
0 Kommentare 0 Geteilt 39 Ansichten 0 Bewertungen